NCT04676321View on ClinicalTrials.gov

Key Performance Indicators for the Assessment of NSCLC Patients Pathway

CompletedOBSERVATIONAL
Enrollment

430

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 15, 2020

Study Completion Date

November 15, 2020

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

Patient pathway

Investigation on the appropriateness and quality of NSCLC care among participating sites

Trial Locations (3)

41125

Policlinico of Modena, Modena

42123

IRCCS Arcispedale S.Maria Nuova, Reggio Emilia

47014

IRST, Meldola

All Listed Sponsors
collaborator

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

collaborator

Azienda Ospedaliera Universitaria Policlinico

OTHER

lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER

NCT04676321 - Key Performance Indicators for the Assessment of NSCLC Patients Pathway | Biotech Hunter | Biotech Hunter